Get In Touch
Have any questions or comments about the content you see on this page?
October 26, 2023
All of us at Alnylam are deeply honored to be named a Science Magazine Top Employer for 2023, which marks our 5th consecutive year on the list and 5th top 5 ranking. This annual ranking is based on survey responses from scientists and other members of the biopharma community.
As a science-based organization, it’s critically important to us that Alnylam be regarded as a great place to work for people looking for a challenging and rewarding career at a company that is at the forefront of scientific discovery. It’s equally important to us to be known for a workplace culture that makes it possible for all of our people to thrive and grow while supporting our mission to deliver transformative RNAi therapies for patients. That’s why ongoing recognition from Science Magazine as a top place to work is so gratifying.” – Kevin Fitzgerald, PhD, Chief Scientific Officer
According to Science, this year's rankings are based on over 6,800 responses from people in in biotechnology (36 percent), biopharmaceuticals (40 percent), pharmaceuticals (20 percent), and other related industries (4 percent) around the world. Survey respondents rated companies on attributes such as innovation, corporate image, leadership and direction, work culture/environment, and academic and intellectual challenge. Geographically, respondents came from North America (59 percent), Europe (18 percent) and Asia/Pacific Rim (16 percent) and rest of world (7 percent). The responses determine which of hundreds of eligible employers make the list of top 20 companies. as well as revealing the behaviors and characteristics that drove their ranking performance.
Alnylam's top characteristics for 2023 were "Treats employees with respect," "Is socially responsible" and "Work-Employee Value Alignment."
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.Proceed to Site